Patent Assignment
Reel/Frame 047455/0385
Patent Security Agreement
Recorded: 2018-11-08
Pages: 7
Assignor
AEGERION PHARMACEUTICALS, INC.
Executed: 2018-11-08
Assignee
NOVELION THERAPEUTICS INC.
1800-510 WEST GEORGIA STREET, VANCOUVER, V6B OM3, CANADA
Covered Properties
(3)
Compound Impurities and Methods of Detecting Same
Methods of Detecting Anti-Leptin Neutralizing Antibodies
Engineered Polypeptides Having Enhanced Duration of Action and Reduced Immunogenicity
Application:
15/882,919 →
Publication:
US 2018/0305430
Related Assignments
(10)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest
Nov 8, 2018
From: AEGERION PHARMACEUTICALS, INC.
To: CANTOR FITZGERALD SECURITIES, AS ADMINISTRATIVE AGENT
Reel/Frame 047447/0926 →
Assignment of Assignor's Interest
Jan 20, 2019
From: GELORMINI, ANN
To: AEGERION PHARMACEUTICALS, INC.
Reel/Frame 048064/0178 →
Security Interest
Sep 24, 2019
From: AEGERION PHARMACEUTICALS, INC.
To: CANTOR FITZGERALD SECURITIES, AS ADMINISTRATIVE AGENT
Reel/Frame 050478/0204 →
Release of Security Interest
Sep 24, 2019
From: CANTOR FITZGERALD SECURITIES, AS ADMINISTRATIVE AGENT
To: AEGERION PHARMACEUTICALS, INC.
Reel/Frame 050478/0629 →
Release of Security Interest
Sep 24, 2019
From: NOVELION THERAPEUTICS INC.
To: AEGERION PHARMACEUTICALS, INC.
Reel/Frame 050478/0695 →
Assignment of Assignor's Interest
May 6, 2020
From: SAILSTAD, JEFFREY
To: AEGERION PHARMACEUTICALS, INC.
Reel/Frame 052590/0679 →
Change of Name
May 10, 2021
From: AEGERION PHARMACEUTICALS, INC.
To: AMRYT PHARMACEUTICALS, INC.
Reel/Frame 056193/0437 →
Security Interest
Feb 18, 2022
From: AMRYT PHARMACEUTICALS, INC.
To: ARES CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 059049/0164 →
Release of Security Interest
Feb 23, 2022
From: CANTOR FITZGERALD SECURITIES, AS ADMINISTRATIVE AGENT
To: AEGERION PHARMACEUTICALS, INC.; AMRYT RESEARCH LIMITED
Reel/Frame 059074/0604 →
Release of Security Interest
Apr 13, 2023
From: ARES CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
To: AMRYT GENETICS LIMITED; AMRYT PHARMACEUTICALS, INC.; AMRYT ENDO, INC.; AMRYT RESEARCH LIMITED
Reel/Frame 063318/0849 →